#glp-1
Latest news and interesting information about glp-1.
Brits Spend $1B Less on Food Due to Weight-Loss Drugs
Weight-loss drugs cause UK food spending to drop $1 billion. Study results and how companies are adapting.
Live Lighter: Novo Nordisk in Azerbaijan
Novo Nordisk introduces new GLP-1 medication for obesity in Azerbaijan.
Genentech to Present Obesity Drug Trial Data at ADA
Genentech presents Phase II data for obesity drugs enicepatide and petrelintide at ADA conference. Latest updates on weight loss treatments.
Could GLP-1 drugs be oncology's next big opportunity?
New research suggests GLP-1 drugs may play a role in cancer prevention and treatment, opening a potential new frontier for these popular therapies.
Poolbeg Pharma Gets FDA Feedback on POLB 001
Poolbeg Pharma receives FDA feedback on POLB 001 for cancer immunotherapy-induced Cytokine Release Syndrome.
Novo, Lilly weight-loss pills lure patients from compounded drugs
Lower prices for Novo Nordisk and Eli Lilly weight-loss pills are driving patients from compounded drugs to branded Wegovy and Foundayo, according to doctors.
William Blair Starts Insulet at Outperform
William Blair initiates Insulet at Outperform. Stock trades at 24x EPS, undervalued per Bond.az. Key concerns and catalysts detailed.
...






